Medicare Enrolled
Dr. Assad Oskuei, M.D.
Pulmonary Disease · Los Alamitos, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oskuei from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oskuei?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oskuei
Dr. Assad Oskuei is a pulmonary disease specialist in Los Alamitos, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Oskuei performed 1,320 Medicare services across 911 unique beneficiaries.
Between the years covered by Open Payments, Dr. Oskuei received a total of $39,574 from 40 pharmaceutical and/or device companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oskuei is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 30% volume in CA
$39,574 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,320
Medicare services
Top 30% in CA for pulmonary disease
911
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
324 | $96 | $370 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
192 | $135 | $470 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
99 | $64 | $230 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
73 | $31 | $190 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
73 | $162 | $702 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
70 | $11 | $70 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
68 | $47 | $179 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
61 | $45 | $174 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
56 | $95 | $350 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
50 | $27 | $109 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
48 | $15 | $48 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $135 | $638 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
32 | $28 | $90 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $100 | $432 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $124 | $522 |
| New patient office visit, complex (60-74 min) | 25 | $175 | $656 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
18 | $98 | $370 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
16 | $13 | $56 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
15 | $8 | $17 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
11 | $39 | $806 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$39,574
Total received (2018-2024)
Avg $5,653/year across 7 years
Top 7% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
552
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,408 (38.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,862 (32.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,304 (28.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$31,846
2023
$2,596
2022
$1,740
2021
$1,648
2020
$841
2019
$781
2018
$121
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$15,244
GENZYME CORPORATION
$12,627
Medtronic, Inc.
$1,649
Actelion Pharmaceuticals US, Inc.
$339
GlaxoSmithKline, LLC.
$324
Amneal Pharmaceuticals LLC
$235
Mylan Specialty L.P.
$220
Amgen Inc.
$178
Mallinckrodt Hospital Products Inc.
$164
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Novartis Pharmaceuticals Corporation
$141
Philips North America LLC
$127
Takeda Pharmaceuticals U.S.A., Inc.
$110
Grifols USA, LLC
$62
Baxter Healthcare
$59
United Therapeutics Corporation
$54
PFIZER INC.
$40
ABBVIE INC.
$29
Regeneron Healthcare Solutions, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$22
Merck Sharp & Dohme LLC
$19
SANOFI PASTEUR INC.
$13
INOGEN, INC.
$9
Top 3 companies account for 92.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$17,434
GENZYME CORPORATION
$13,050
Medtronic, Inc.
$1,649
GlaxoSmithKline, LLC.
$1,273
Boehringer Ingelheim Pharmaceuticals, Inc.
$906
Genentech USA, Inc.
$620
Novartis Pharmaceuticals Corporation
$539
Mylan Specialty L.P.
$472
Grifols USA, LLC
$418
Actelion Pharmaceuticals US, Inc.
$412
Takeda Pharmaceuticals U.S.A., Inc.
$353
Mallinckrodt Hospital Products Inc.
$324
Amgen Inc.
$291
PFIZER INC.
$274
Amneal Pharmaceuticals LLC
$235
United Therapeutics Corporation
$138
Regeneron Healthcare Solutions, Inc.
$131
Philips North America LLC
$127
Baxter Healthcare
$96
Janssen Pharmaceuticals, Inc
$90
Philips Electronics North America Corporation
$86
Insmed, Inc.
$82
Alexion Pharmaceuticals, Inc.
$69
Teva Pharmaceuticals USA, Inc.
$60
Covis Pharma GmBH
$50
ABBVIE INC.
$50
Advanced Respiratory, Inc
$43
Sunovion Pharmaceuticals Inc.
$39
Merck Sharp & Dohme LLC
$38
Inogen, Inc.
$31
Electromed, Inc.
$30
SANOFI PASTEUR INC.
$29
Inspire Medical Systems, Inc.
$28
E.R. Squibb & Sons, L.L.C.
$22
Boston Scientific Corporation
$19
Merck Sharp & Dohme Corporation
$18
Paratek Pharmaceuticals, Inc.
$15
Bio Products Laboratory USA, Inc.
$14
ADVANCED RESPIRATORY, INC
$12
INOGEN, INC.
$9
Top 3 companies account for 81.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · ANGIOJET · ANORO ELLIPTA · AREXVY · AVYCAZ · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · CUVITRU · DUPIXENT · ELIQUIS · Esbriet · FARXIGA · FASENRA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GLASSIA · Gammaplex · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · ILLUMISITE · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · LONHALA MAGNAIR · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · PANZYGA · PREVNAR 13 · PREVNAR 20 · Perforomist · Prolastin-C Liquid · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · The VitalCough System · ULTOMIRIS · UPTRAVI · Ultomiris · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (39%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for pulmonary disease in CA.
Geographic Context
Pulmonary diseases within 10 mi
210
Per 100K population
6.6
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oskuei is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with mixed engagement industry engagement in the top 7% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oskuei experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Oskuei performed 324 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oskuei receive payments from pharmaceutical companies?
Yes. Dr. Oskuei received a total of $39,574 from 40 companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oskuei's costs compare to other pulmonary diseases in Los Alamitos?
Dr. Oskuei's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oskuei) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Los Alamitos
Browse pulmonary diseases in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology